EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 32 / No 1 (2026) J Oral Med Oral Surg, 32 1 (2026) 9 References
Open Access
Issue
J Oral Med Oral Surg
Volume 32, Number 1, 2026
Article Number 9
Number of page(s) 9
DOI https://doi.org/10.1051/mbcb/2026009
Published online 13 May 2026
  1. Chae MP, Smoll NR, Hunter-Smith DJ, Rozen WM. Establishing the natural history and growth rate of ameloblastoma with implications for management: systematic review and meta-analysis. PLoS One 2015;10:e0117241. [Google Scholar]
  2. DeVilliers P, Suggs C, Simmons D, Murrah V, Wright JT. Microgenomics of ameloblastoma. J Dent Res 2011;90:463-469. [Google Scholar]
  3. Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: Current etiopathological concepts and management. Oral Dis 2018;24:307-316. [Google Scholar]
  4. Hendra FN, Natsir Kalla DS, Van Cann EM, de Vet HCW, Helder MN, Forouzanfar T. Radical vs conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis. Oral Dis 2019;25:1683-1696. [Google Scholar]
  5. Gimenez-Conti IB, et al. p53, Rb and cyclin D1 expression in human oral verrucous carcinomas. Cancer 1996;78:17-23. [Google Scholar]
  6. Kitkumthorn N, Yanatatsaneejit P, Rabalert J, Dhammawipark C, Mutirangura A. Association of p53 codon 72 polymorphism and ameloblastoma. Oral Dis 2010;16:631-635. [Google Scholar]
  7. Sharifi-Sistani N, Zartab H, Babakoohi S, Saghravanian N, Jamshidi S, Esmaili H, et al. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors. J Craniofac Surg 2011;22:1652-1656. [Google Scholar]
  8. Gadbail AR, Patil R, Chaudhary M. Co-expression of Ki-67 and p53 protein in ameloblastoma and keratocystic odontogenic tumor. Acta Odontol Scand 2012;70:529-535. [Google Scholar]
  9. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, Eds. Cochrane handbook for systematic reviews of interventions, 2008. [Google Scholar]
  10. Adesina OM, Adebiyi KE, Effiom OA, Omoniyi-Esan GO, Owotade FJ, Fatusi OA, et al. Comparative immunohistochemical analysis of p53 and Alpha-SMA in ameloblastoma, AOT and OKC. West Afr J Med 2022;39:248-255. [Google Scholar]
  11. Shaikh Z, Niranjan KC. Cell cycle aberration in ameloblastoma and adenomatoid odontogenic tumor: As evidenced by the expression of p53 and survivin. Indian J Dent Res 2015;26:565-570. [Google Scholar]
  12. Loyola AM, Cardoso SV, de Faria PR, Servato JPS, Eisenberg ALA, Dias FL, dos Santos JN. Ameloblastic carcinoma: a Brazilian collaborative study of 17 cases. Histopathology 2016;69:687-701. [Google Scholar]
  13. You Z, Sun L, Yan X, Zhang J, Du J, Li T, Zhao H. Clinicopathologic study on a rare variant of ameloblastoma with basal cell features. Oral Dis 2019;25:788-795. [Google Scholar]
  14. Tenório JR, Santana T, Queiroz SIML, de Oliveira DHIP, Queiroz LMG. Apoptosis and cell cycle aberrations in epithelial odontogenic lesions: an evidence by the expression of p53, Bcl-2 and Bax. Med Oral Patol Oral Cir Bucal 2018;23:e120-e125. [Google Scholar]
  15. Singh A, Jain A, Shetty DC, Rathore AS, Juneja S. Immunohistochemical expression of p53 and murine double minute 2 protein in odontogenic keratocyst versus variants of ameloblastoma. J Can Res Ther 2020;16:521-529. [Google Scholar]
  16. Salehinejad J, Zare-Mahmoodabadi R, Saghafi S, Jafarian AH, Ghazi N, Rajaei AR, Marouzi P. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor. J Oral Sci 2011;53:213-217. [Google Scholar]
  17. Beppu T, Ishikawa A, Hamahata A. A case of ameloblastoma presenting a remarkably increased cell proliferation and clinical invasiveness in short time course: Does this case show an early period of dedifferentiation? J Oral Maxillofac Surg Med Pathol 2015;27:432-437. [Google Scholar]
  18. Kato H, Ota Y, Sasaki M, Karakida K, Kaneko A, Sekido Y, Tsukinoki K. Peripheral ameloblastoma of the lower molar gingiva: a case report and immunohistochemical study. Tokai J Exp Clin Med 2012;37:30-34. [Google Scholar]
  19. Florescu A, Simionescu C, Ciurea R, Pitru A. P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas. Rom J Morphol Embryol 2012;53:105-109. [Google Scholar]
  20. de Vicente JC, Torre-Iturraspe A, Gutiérrez AM, Lequerica-Fernández P. Immunohistochemical comparative study of the odontogenic keratocysts and other odontogenic lesions. Med Oral Patol Oral Cir Bucal 2010;15:e709-e715. [Google Scholar]
  21. Adorno-Farias D, Muniz VRVM, Soares AP, Cury PR, Rabelo RG, Fernández-Ramires R, dos Santos JN. Ameloblastoma with adenoid features: a series of eight cases. Acta Histochem 2018;120:468-476. [Google Scholar]
  22. Singh T, Chandu A, Clement J, Angel C. Immunohistochemistry of five molecular markers for typing and management of ameloblastomas: a retrospective analysis of 40 cases. J Maxillofac Oral Surg 2016;16:65-70. [Google Scholar]
  23. Loyola AM, Cardoso SV, de Faria PR, Servato JPS, Eisenberg ALA, Dias FL, et al. Adenoid ameloblastoma: clinicopathologic description of five cases and systematic review of the current knowledge. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:368-377. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.